ライフサイエンスコーパス: anti-glomerular

1 lagellin, respectively, all could facilitate anti-glomerular Ab-elicited nephritis.

2 e receive nephrotoxic serum (NTS) containing anti-glomerular antibodies.

3 Two different proliferative forms of anti-glomerular basal membrane (GBM) GN in rats were ind

4 ession of HB-EGF in rat kidneys treated with anti- glomerular basement membrane (anti-GBM) antibody (

5 partment developed glomerulonephritis in the anti-glomerular basement disease model, whereas nontrans

6 Urine samples from mice with anti-glomerular basement membrane (anti-GBM) antibody-in

7 The pathophysiology of anti-glomerular basement membrane (anti-GBM) disease bef

8 roblast recruitment in renal fibrosis due to anti-glomerular basement membrane (anti-GBM) disease is

9 their kidneys as a result of posttransplant anti-glomerular basement membrane (anti-GBM) disease.

10 The anti-glomerular basement membrane (GBM) Ab has been rega

11 immunoperoxidase assay on cell layers using anti-glomerular basement membrane (GBM) antibodies.

12 l chemoattractant, during the progression of anti-glomerular basement membrane (GBM) antibody (Ab) GN

13 Anti-glomerular basement membrane (GBM) antibody nephrit

14 f inflammation and in the progression of the anti-glomerular basement membrane (GBM) antibody-induced

15 Anti-glomerular basement membrane (GBM) disease is a rap

16 Human anti-glomerular basement membrane (GBM) disease strongly

17 We developed a new mouse model of human anti-glomerular basement membrane (GBM) disease to bette

18 We developed a rat model of human anti-glomerular basement membrane (GBM) disease to inves

19 obulin G (IgG) and complement C3, typical of anti-glomerular basement membrane (GBM) disease.

20 ere, macrophage-mediated, cytokine-dependent anti-glomerular basement membrane (GBM) glomerulonephrit

21 inflammation, the development of accelerated anti-glomerular basement membrane (GBM) glomerulonephrit

22 autologous phase of an accelerated model of anti-glomerular basement membrane (GBM) glomerulonephrit

23 in vivo, we induced a model of Fc-dependent anti-glomerular basement membrane (GBM) nephritis in wil

24 Alport posttransplantation anti-glomerular basement membrane (GBM) nephritis is med

25 s to monitor renal disease progression in an anti-glomerular basement membrane (GBM) nephritis mouse

26 e subjected to an augmented passive model of anti-glomerular basement membrane (GBM)-induced experime

27 f glomerulonephritis induced by heterologous anti-glomerular basement membrane Abs in wild-type (IL-4

28 initiated by binding of heterologous (sheep) anti-glomerular basement membrane Abs to the glomeruli o

29 ls of experimental glomerulonephritis, being anti-glomerular basement membrane and lipopolysaccharide

30 distinct, separate disease process, such as anti-glomerular basement membrane antibodies or anti-neu

31 s characterized by circulating and deposited anti-glomerular basement membrane antibodies, focal necr

32 ies has been known to occur with exposure to anti-glomerular basement membrane antibody (AGBM-Ab) in

33 Injection of sheep anti-glomerular basement membrane antibody into preimmun

34 In GEC(HO-1) rats with anti-glomerular basement membrane antibody mediated, com

35 lowing parameters both at baseline and after anti-glomerular basement membrane antibody treatment: bl

36 triggered GN with a subnephritogenic dose of anti-glomerular basement membrane antibody, Aire(-/-) mi

37 issolution of NETs via DNase I did not alter anti-glomerular basement membrane antibody-induced glome

38 ly modulates iNOS expression and activity in anti-glomerular basement membrane antibody-mediated glom

39 y immunizing mice with MPO and a low dose of anti-glomerular basement membrane antibody.

40 lonephritis induced by the administration of anti-glomerular basement membrane antibody.

41 Introduction of heterologous anti-glomerular basement membrane antiserum (nephrotoxic

42 s induced with a previously described rabbit anti-glomerular basement membrane antiserum nephritis ap

43 mediated by pathogenic antibodies, including anti-glomerular basement membrane disease and lupus neph

44 d a macrophage- and T-cell-mediated model of anti-glomerular basement membrane disease in STC1 transg

45 nt nephritis (APTN) is an aggressive form of anti-glomerular basement membrane disease that targets t

46 US/TTP), 8; systemic lupus erythematosus, 3; Anti-glomerular basement membrane disease, 2; oxalosis,

47 ytoplasmic antibodies-associated vasculitis, anti-glomerular basement membrane disease, and systemic

48 severe glomerulonephritis after induction of anti-glomerular basement membrane disease, with more inf

49 l approach to the treatment of patients with anti-glomerular basement membrane disease.

50 n of glomerulonephritis after induction with anti-glomerular basement membrane globulin, with enhance

51 ological characteristics during experimental anti-glomerular basement membrane glomerulonephritis (an

52 is, we compared the intensity of accelerated anti-glomerular basement membrane glomerulonephritis bet

53 ed: a diffuse type that is characteristic of anti-glomerular basement membrane glomerulonephritis, an

54 Anti-glomerular basement membrane GN involved NET format

55 Accelerated anti-glomerular basement membrane GN was examined in gro

56 We used lupus and anti-glomerular basement membrane models of nephritis to

57 ive glomerulonephritis, type I and II (MPG), anti-glomerular basement membrane nephritis (anti-GBM),

58 and dedifferentiated podocytes of mice with anti-glomerular basement membrane nephritis and in human

59 Using anti-glomerular basement membrane nephritis in rats, we

60 Moreover, after induction of anti-glomerular basement membrane nephritis in young mic

61 necessary for local chemokine expression in anti-glomerular basement membrane nephritis, although th

62 /c control mice, were challenged with rabbit anti-glomerular basement membrane nephrotoxic sera (NTS)

63 kidney inflammation in a macrophage-mediated anti-glomerular basement membrane reactive serum-induced

64 Compared with wild-type mice, after anti-glomerular basement membrane treatment STC1 transge

65 In Goodpasture's (anti-glomerular basement membrane) disease, autoimmunity

66 erular neutrophil accumulation and damage in anti-glomerular basement membrane-induced (anti-GBM-indu

67 Similarly, both anti-glomerular basement membrane-induced glomerulonephr

68 ntaneous chronic glomerulonephritis (GN) and anti-glomerular basement membrane-induced nephritis.

69 In rats, intrarenal arterial injection of anti-glomerular endothelial cell (GEN) antibodies leads